Welcome: Guest | Site Use Options | Register | Login |

Macrogenics Inc

Macrogenics Inc

Profile last edited on: 6/6/2019
9640 Medical Center Drive
Rockville, MD 20850
  (301) 251-5172
Business Identifier: Antibody-based therapies for autoimmune and infectious diseases and cancer
Public Profile:
Macrogenics Inc is focused on exploiting the mechanisms by which cytotoxic antibodies mediate cell killing both for the development and improvement of existing therapeutic antibodies for the treatment of cancers and the development of therapeutics to prevent cytotoxic autoantibodies from triggering disease in autoimmunity. The firm is focused on product development derived from in-house and from in-licensed candidates in the areas of oncology, autoimmunity, antibody engineering and infectious disease. This multi-faceted approach in developing both antibodies and vaccines provides a diversified strategy for creating novel immunotherapeutics in areas of unmet medical need.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920